LeMaitre Vascular, Inc. (LMAT)
| Market Cap | 1.05B |
| Revenue (ttm) | 158.10M |
| Net Income (ttm) | 27.02M |
| Shares Out | 22.19M |
| EPS (ttm) | 1.24 |
| PE Ratio | 38.29 |
| Forward PE | 37.17 |
| Dividend | $0.47 (0.99%) |
| Ex-Dividend Date | May 16, 2022 |
| Volume | 25,074 |
| Open | 46.38 |
| Previous Close | 46.08 |
| Day's Range | 45.86 - 47.49 |
| 52-Week Range | 38.32 - 61.02 |
| Beta | 1.28 |
| Analysts | Buy |
| Price Target | 61.05 (+28.6%) |
| Earnings Date | Aug 4, 2022 |
About LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the ... [Read more...]
Financial Performance
In 2021, LMAT's revenue was $154.42 million, an increase of 19.37% compared to the previous year's $129.37 million. Earnings were $26.91 million, an increase of 26.80%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is 61.05, which is an increase of 28.58% from the latest price.
News
LeMaitre to Present at the Sidoti Summer Small Cap Virtual Conference
BURLINGTON, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Sidoti Summer Small Cap Virtual Conference o...
LeMaitre to Present at Upcoming Investor Conferences
BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -3.57% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Q1 2022 Financial Results
BURLINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2022 results, announced a $0.125/share quarterly di...
LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022
BURLINGTON, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, aft...
Is This Overlooked Stock a Buy After Its Dividend Hike?
LeMaitre Vascular could be a hidden gem for dividend growth investors.
LeMaitre to Present at the Needham Virtual Healthcare Conference
BURLINGTON, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 21st Annual Needham Virtual H...
LeMaitre Joins NASDAQ Dividend Achievers Index – 10 Years of Dividend Increases
BURLINGTON, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it has joined the NASDAQ US Broad Dividend Achie...
LeMaitre to Participate at Upcoming Investor Conferences in March
BURLINGTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre Vascular (LMAT) Misses Q4 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -9.68% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Q4 2021 Financial Results
BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly div...
Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022
BURLINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, ...
LeMaitre to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health, ...
AHCO vs. LMAT: Which Stock Should Value Investors Buy Now?
AHCO vs. LMAT: Which Stock Is the Better Value Option?
LeMaitre to Present at the Needham Virtual Growth Conference
BURLINGTON, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 24th Annual Needham Virtual Gr...
Why You Should Consider Buying This Little-Known Medical Devices Stock
LeMaitre Vascular is a small-cap medical devices maker with the potential to continue growing rapidly in the years ahead.
LeMaitre to Participate at Upcoming Investor Conferences
BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences.
LeMaitre Vascular (LMAT) Lags Q3 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -9.09% and -2.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: LeMaitre Vascular Q3 Earnings
LeMaitre Vascular (NASDAQ:LMAT) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM. Here's what investors need to know about the announcement.
LeMaitre Q3 2021 Financial Results
BURLINGTON, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2021 results, announced an $0.11/share quarterly div...
LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
BURLINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results on Thursday, October 28, 2021, af...
LeMaitre Vascular to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September.
Is This Under-the-Radar Medical Device Company a Post-Earnings Buy?
LeMaitre Vascular's operating fundamentals and balance sheet suggest it's a buy, depending on your objectives.